What is known about #kidneycancer risk factors and genetic testing? Dr. Moshe Ornstein from Cleveland Clinic explains known factors and genetic testing recommendations. ow.ly/tf2q50Rp3sh #RCC

What can #myeloma consults and second opinions bring to patients? C. Ola Landgren, M.D. of Miller Medicine shares his perspective on the benefits. ow.ly/Rlpc50Rp33t #mmsm

How can shared decision-making benefit #AML patient care? Dr. Sara Taveras from UTHealth Houston explains how she sets expectations from diagnosis and through treatment. ow.ly/pNes50Rp2Oe #AML sm #leusm

Bright Spot Network Bright Spot Network co-founder, Haley Pollack, discusses her #coloncancer diagnosis and shares tips for parenting with cancer. powerfulpatients.org/2024/04/25/tip…

Are you or do you know someone who is a cancer survivor living in or near rural Appalachia?

Are you/they looking for support to make healthy lifestyle changes?

If you want to learn more about the weSurvive study, scan the QR code or click here: virginiahsd.co1.qualtrics.com/jfe/form/SV_0r…

How can #myeloma patients plan and prepare for #CART cell therapy? Beth Faiman PhD from Cleveland Clinic shares an overview. ow.ly/8q1k50Ro8pG #bloodcancer #MMsm

The IWMF is hosting its 2024 Ed Forum May 3-5 for WM patients and caregivers. Don’t miss out! Register Today! tinyurl.com/3wawduhv
#iwmf2024EdForum #Waldenstroms

Marie Ennis-O'Connor Marie Ennis-O'Connor shares how to launch a Substack, a user-friendly publishing platform that is gaining popularity in patient advocacy. ow.ly/zZCY50RnjpS

In this podcast, Dr. Gaby Hobbs Mass General Cancer Center discusses updates in research, the role of emerging #myelofibrosis therapies, and shares advice for accessing quality care. ow.ly/uf6M50Rnj1V #mpnsm #MF

In this podcast, Dr. Gaby Hobbs discusses updates in research, the role of emerging #myelofibrosis therapies, and shares advice for accessing quality care. Link in bio #mpnsm #MF

🌟 'Alone we can do so little; together we can do so much.' - Helen Keller 🌟
@Power4Patients is excited to celebrate our partner The Leukemia & Lymphoma Society to empower more cancer patients and their families! Together, we're stronger. 💪🎗️ #Unity #CancerCare #Partnership

What are the latest advances in #myelofibrosis therapy? Gaby Hobbs from Mass General Cancer Center shares an overview. ow.ly/kYTo50RmcfH #MPNsm #bloodcancer

What are #AML diagnosis disparities? Dr. Sara Taveras Alam from UTHealth Houston discusses disparity factors and patient advice for newly diagnosed AML patients. ow.ly/iVZV50Rmc1Z #AML sm #leusm

What are the current #prostatecancer treatment options? Register for our webinar on 5/14 with Rana McKay of UC San Diego Health to learn more: ow.ly/Kvpp50Rgcnl #pcsm

What should patients know about #headandneckcancer treatment and research? Ezra Cohen from Tempus shares his perspective. ow.ly/9Riz50RmbQW #hncsm

🌎💪 This #EarthDay , let's connect the dots between a healthy planet and our health. At @Power4Patients, we empower patients by advocating for a clean, sustainable environment that supports our well-being. Join us in making eco-friendly choices! #HealthForAll

What’s important for newly diagnosed #RCC patients to know? Dr. Moshe Ornstein from Cleveland Clinic discusses his approach to communicating and educating these patients. ow.ly/E1Yx50Rl7Rn #kidneycancer

How can #endometrialcancer care barriers be overcome in regards to geographic location? Dr. Emily Hinchcliff from Northwestern Medicine shares insight and advice. ow.ly/sRiv50Rl7zR #gyncsm

What are the advantages to #myeloma patients for #CART cell therapy over other treatments? Beth Faiman PhD from Cleveland Clinic explains. ow.ly/yhEY50Rl7i5 #mmsm

How are primary myelofibrosis and secondary #myelofibrosis defined? Gaby Hobbs from Mass General Cancer Center explains the difference. ow.ly/R5zE50RjQnm #MPNsm #bloodcancer